The run of luck for the company has changed finally after restructuring and FCCB woes were mostly disposed off as the medicine major brought back 43% jump in sales to INR14.3B and has doubled profits from INR 1.94 Bln odd to INR3.8B, despite RM casts having jumped from 24B to 41B

Posted via email from The India Investment Post